Hepatitis C virus (HCV) has multiple genotypes of which genotype 1 is the most common in the United States. Cirrhosis does not develop in all patients infected with HCV. Elevated serum ...

When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary staging ...

Hepatitis C virus (HCV)-related diseases such as chronic hepatitis C, liver cirrhosis, and liver cancers afflict a large number of people worldwide. A recent study from Korea University suggests that ...

HCV infection is the underlying cause for chronic Hepatitis C (CHC), liver cirrhosis, and liver cancer or hepatocellular carcinoma (HCC). In 2019, over 2,90,000 people died of HCV-related diseases.

Please provide your email address to receive an email when new articles are posted on . Nearly 97% of patients achieved sustained virologic response at 12 weeks after treatment with ...

Hepatitis C is a type of blood-borne virus that targets the liver, causing inflammation and liver damage if untreated. It spreads between people by blood-to-blood contact. In cases covered by the ...

Please provide your email address to receive an email when new articles are posted on . Cumulative incidence rates of HCC longitudinally increased over 5 years, although recurrence plateaued. Survival ...

End stage hepatitis C occurs when the infection has progressed to such a degree that it has damaged the liver irreversibly. Symptoms at this stage may include jaundice and abdominal swelling.

Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists have lacked an animal model that faithfully recapitulates how the disease ...